The Patent Finder

Novel Benzodiazepine Derivatives

ImmunoGen, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 61/150,201, filed Feb 5, 2009. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,802,667Novel Benzodiazepine Derivatives
In force
 · High confidence
UsedRemaining
ImmunoGen, Inc.In forceHigh confidence
US 8,809,320Novel Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 9,265,841Novel Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 9,550,787Novel Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 10,208,127Novel Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 10,947,315Novel Benzodiazepine Derivatives
In force
 · Medium confidence
ImmunoGen, Inc.In forceMedium confidence
US 11,505,617Novel Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen, Inc.In forceHigh confidence
US 8,426,402Novel Benzodiazepine Derivatives
In force
 · High confidence
ImmunoGen Inc.In forceHigh confidence
Application 15/371,738Novel Benzodiazepine Derivatives
Abandoned
Abandoned Oct 17, 2017
ImmunoGen, Inc.AbandonedAbandoned Oct 17, 2017
Application 15/676,316Novel Benzodiazepine Derivatives
Abandoned
Abandoned Aug 14, 2018
ImmunoGen, Inc.AbandonedAbandoned Aug 14, 2018
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited